Production at several major pharmaceutical factories in Puerto Rico was disrupted for months in 2017 after Hurricane Maria tore across the island — leaving hospitals without a reliable supply of saline IV bags and other infused fluids. Less than a year later, manufacturing problems at several other U.S. plants caused nationwide shortages of opioids used in surgeries and end-of-life care.
More than 450,000 people in the United States have been infected with the coronavirus so far, and hot spots are emerging in places like Pennsylvania, Colorado and Washington, D.C. The agency has cut allowed production caps for those and other opioids by 54 percent since 2016, a senior DEA official said. Manufacturers that want to make more of the medications in response to the coronavirus pandemic will still need government permission, even to produce the injectable opioids used mainly by hospitals, not people who misuse drugs.
Industry groups said the Food and Drug Administration has also been in touch with manufacturers to speed up supplies by relaxing its rules around switching production lines. The agency also this week approved a generic version of the commonly used asthma inhaler albuterol, which is being prescribed to many coronavirus patients.
“While manufacturers are required to report certain information related to drug supply disruptions to FDA, they are not required to provide detailed information on their supply chain that be helpful for monitoring the drug supply,” an agency spokesperson said. “We rely on the cooperation of the drug companies in order to obtain accurate information as we proactively take steps to mitigate drug shortages.
If you can eat it, you can beat it. marijuana
This makes no sense. It is already essentially impossible to get any opioid, for any reason, here in the Northeast. Period. Basically full prohibition. CrazyRxMan
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: peoplestyle - 🏆 367. / 59 Read more »
Source: WSJ - 🏆 98. / 63 Read more »
Source: Allure_magazine - 🏆 473. / 51 Read more »
Source: Newsweek - 🏆 468. / 52 Read more »